Galmed Pharmaceuticals Invests 50% of Cash Reserves in Crypto

Galmed Pharmaceuticals has made a bold move by allocating 50% of its $10 million cash reserves to digital assets, marking a significant shift for the biopharma industry. The company plans to utilize these funds strategically through DeFi strategies like staking and liquidity provision, aided by Tectona Ltd., a specialized treasury management service provider. This decision signals a proactive approach to managing capital in a way that could potentially yield higher returns while increasing diversification.